Rheumatoid arthritis (RA) is a chronic and potentially debilitating autoimmune disease. While novel therapies have emerged in recent years, disease remission is rarely achieved. RA is a complex trait, and the identifying of its susceptibility and severity genes has been anticipated to generate new targets for therapeutic intervention. However, finding those genes and understanding their function has been a challenging task. Studies in rodent intercrosses and congenics generated from inbred strains have been an important complementary strategy to identify arthritis genes, and understand how they operate to regulate disease. Furthermore, these new rodent arthritis genes will be new targets for therapeutic interventions, and will identify new candidate genes or candidate pathways for association studies in RA. In this review-opinion article I discuss RA genetics, difficulties involved in gene identification, and how rodent models can facilitate (1) the discovery of both arthritis susceptibility and severity genes, (2) studies of gene-environment interactions, (3) studies of gene-gender interactions, (4) epistasis, (5) functional characterization of the specific genes, (6) development of novel therapies and (7) how the information generated from rodent studies will be useful to understanding and potentially treating RA.
Introduction
Rheumatoid arthritis (RA) is one of the most frequent autoimmune diseases with a prevalence of approximately 1% in most populations. RA is associated with pain, disability, deformities and reduced quality of living and reduced life expectancy. Understanding the pathogenic processes regulating RA and joint destruction is a critical step toward developing better therapies. Four basic strategies have been taken to understand RA and to identify potentially new therapeutic targets and prognostic biomarkers: (a) functional and gene expression studies with human tissues and cells followed by their correlation with clinical characteristics and disease outcome; (b) genetic studies in families or in case-controls; (c) functional studies in experimental models of arthritis in rodents and (d) genetic studies in rodent models of arthritis. In this article I discuss some of the main contributions of rodent-based genetic studies to the understanding of the pathogenesis of RA, and how those studies are anticipated to generate new targets for therapeutic intervention. (The reader is referred to several comprehensive reviews listing rat and mouse arthritis loci, their specific chromosome location, and more extensive details about the different models of arthritis). [1] [2] [3] Human studies and obstacles to the identification of RA susceptibility genes RA is a complex trait, and there is evidence for a strong MHC and non-MHC genetic component in its regulation. 4 Several susceptibility loci have been identified in family-based linkage studies, [5] [6] [7] [8] [9] [10] [11] [12] [13] yet until very recently none of those studies had led to the identification of new disease genes. The exciting exception came very recently with the discovery that STAT4 accounts for the 2q33 locus (Peter K Gregersen, personal communication). 14 Association studies identified PTPN22, CTLA-4, PADI-4, [15] [16] [17] IkBL 18 and SCL22A4 19 as susceptibility genes, but only the first three, particularly PTPN22 have been replicated. While these new findings have generated great excitement, it remains unclear how these genes operate to regulate disease, and whether they will become feasible targets for therapeutic intervention.
Obstacles involved in gene identification include the intrinsic characteristics of complex traits, such as variable penetrance of disease alleles, variable relative-risk associated with different disease alleles requiring large populations for their detection, among others. 20 In addition, we are just beginning to understand the extent that population admixtures influence the results of association studies. 21, 22 More recent technologic developments and the identification of sets of markers that differentiate ethnic admixture are making high-density genome-wide associations a promising reality. 23, 24 Genetic studies using rodent models of arthritis
The study of rodent models of arthritis is a powerful and complementary approach for RA gene discovery. Arthritis can be studied in inducible or spontaneous models. In either case, the difference in susceptibility or severity, in the same environment, is clearly genetically regulated and can be mapped in backcross or intercross offspring followed by phenotyping (arthritis) and genome-wide quantitative trait loci (QTL) analysis. Both inducible and spontaneous models are informative to the understanding of RA. Specifically, while RA is known to have a strong genetic component, the 30% maximum concordance between monozygotic twins 4 is evidence that environmental and stochastic events are required for the development of disease. Therefore, inducible models of arthritis are highly informative to study environmentdependent gene effects, such as those induced by different oils and adjuvants. It is conceivable that some of the environmental risk factors associated with RA, such as decaffeinated coffee 25 or smoking 26, 27 modulate the expression of disease alleles, perhaps with adjuvantlike activity. Of additional interest to rodent models of arthritis induced with arthritogenic oils, a recent study suggested that exposure to mineral oils is a risk factor for RA. 28 Furthermore, the inducible models described below are complex traits, similar to RA.
Inducible models
Arthritis can be induced with injections of type II collagen (collagen-induced arthritis, (CIA)) or proteoglycan combined with adjuvant oils, with complete Freund's adjuvant (adjuvant-induced arthritis, (AIA)), pristane (pristane-induced arthritis, (PIA)), squalene, incomplete Freund's adjuvant, 1 or by transfer of serum from K/B Â N TCR-transgenic mice. 29 Certain inbred strains of mice and rats are highly susceptible to these models, while other strains are resistant. Susceptible strains typically develop symmetric and persistent arthritis with histologic characteristics that mimic those of RA. 1, [30] [31] [32] Disease onset can be timed with reasonable precision and specimens (serum, synovium, blood or lymphnode cells) collected in a systematic manner for functional studies or gene expression analysis during pre-clinical stages, early disease or chronic erosive stages.
The difference in susceptibility to and severity of arthritis between rodent inbred strains is genetically regulated. Therefore, genes accounting for the phenotypic differences can be mapped in linkage/QTL studies conducted in backcrosses or intercrosses generated between susceptible and resistant strains. Using this strategy, several arthritis and arthritis-related phenotypes have been studied. This approach reduces genetic heterogeneity, and since experiments are conducted in controlled conditions, environmental confounding factors are diminished. Studies in rodent intercrosses identified several arthritis susceptibility, severity and chronicity loci (Table 1) . 29, [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] The RA genome-wide family-based genetic studies were not designed or structured to address disease severity, histologic damage or the other arthritis-related phenotypes that can be studied in rodents. More recent cohorts have been incorporating severity and outcome parameters in their prospective data collection and will likely have a major role in RA severity genetic association studies. 28, 46, 47 It is anticipated that the rodent arthritis gene identification will generate novel candidate genes or candidate pathways for genetic analysis in humans. Additionally, genes identified in rodents can be more easily functionally characterized to generate new targets for drug development. Cia12/Pia4/Cia25 12 12p13-q24 MS 109, 110 , IDDM 24 , CD 103, 106 , IBD 106 Abbreviations: RA, rheumatoid arthritis; Aia, adjuvant-induced arthritis; CD, Crohn's disease; Cia, collagen-induced arthritis; IDDM, insulindependent diabetes mellitus; MS, multiple sclerosis; Oia, oil-induced arthritis; Pia, pristane-induced arthritis; PS, psoriasis; SLE, systemic lupus erythematosus; UC, ulcerative colitis.
Spontaneous models
Spontaneous arthritis can occur as result of spontaneous mutations, such as described in Zap70 (recessive), 48 or following N-ethyl-N-nitrosourea (ENU) mutagenesis, as described with Plcg2 (dominant), 49 which can then be mapped/positionally cloned with linkage/QTL analysis. While neither Zap70 nor Plcg2 have yet been implicated in the genetic susceptibility to RA, and both induced monogenic traits unlike RA, their discoveries underscore the importance of T cells and their thymic selection and the role of B-cell activation in arthritis, respectively.
To our knowledge there has been no systematic ENU-induced effort aimed at identifying arthritis mutants, and spontaneous arthritis mutants such as Zap70 are uncommon. Obviously, genetic manipulations of specific genes previously implicated in the pathogenesis of arthritis and autoimmunity have been studied such as in gp130 knock-in, 50 IL-1ra knock-out 51 and TNFa transgenic mice; 52 however, this is not a strategy aimed at identifying new disease genes.
Why study different models of autoimmune arthritis?
Several QTL regulating different models of autoimmune arthritis colocalize or are located in syntenic regions in the mouse and rat genomes. These observations underscore the importance of those loci/genes and suggest that they are central to different pathogenic processes that lead to arthritis, and not just to a specific model or in the response to a single adjuvant. These QTL and genes critical to different models of arthritis are anticipated to also be relevant to RA.
Certain processes, however, may be more relevant to one type of arthritis model than to another, and yet, relevant to RA. For example, DA Â F344 F2 intercrosses studied for CIA identified six non-MHC loci, 40, 43 while the same intercross studied for AIA led to the identification of only three non-MHC loci. Of these, only one non-MHC locus, Cia3/Aia3, was common to both models, while the others were model specific. Subsequent studies in congenic strains in fact showed that the CIA QTL also regulate oil-induced arthritis and PIA, underscoring the importance of using more than one model during the QTL discovery stage. Therefore, studies of different models of arthritis allow for the identification of an increased number of candidates that can then be tested in human disease.
Using congenic strains to identify genes and their functions
Another strength of studying rodent models is that discoveries from linkage studies can be confirmed in congenic strains before gene identification efforts. Specifically, a chromosomal interval containing an arthritis gene, based on linkage studies in backcrosses or intercrosses can be transferred from the resistant strain into the susceptible strain background (or vice versa) using genotype-guided breeding strategies. The effect of this single locus in disease severity can then be studied. Several congenic strains have been generated by different groups and their arthritis-regulatory effect confirmed.
30,31,53-58 Our group and others have significantly refined different critical intervals containing arthritis genes and are now in the final stages of positional cloning.
In one case, a specific gene, Ncf1, was identified by Olofsson et al. 59 as a novel autoimmune arthritis gene accounting for Pia4. In this case, the disease-favoring allele was unexpectedly associated with reduced production of reactive oxygen species, which caused increased survival of autoreactive T cells. 59 These findings led to the use of activators of the NADPH pathway as a way of treating arthritis. Recent evidence implicates interferon-b as a mediator of NAPDH-enhancing disease amelioration. 60 The human NCF1 gene has two pseudogene duplications, 61, 62 and has proven difficult to study in humans.
It is considered that rodent arthritis genes will regulate at least some cellular functions or cell subsets already implicated in the pathogenesis of arthritis. Therefore, those functions could be studied in congenics and compared with the parental strains, providing early clues to arthritis gene function. For example, while synovial hyperplasia, angiogenesis and lymphocytic infiltration are detected in preclinical stages of arthritis in rodents 63, 64 and humans, 65, 66 the presence of neutrophils in the joints appears to correlate with disease onset. Therefore, better understanding the processes regulating neutrophil migration into the joint cavity could identify potentially novel ways of treating disease. Studies of several congenic strains determined that Cia4, Cia6 and Cia7 regulate neutrophil migration into a synovial-like cavity. 67, 68 Furthermore, it was determined that Cia4 regulates levels of TNFa at the inflammatory site, while Cia6 regulates levels of nitric oxide (NO). This was the first time that non-MHC and non-iNOS/eNOS arthritis loci were implicated in the regulation of TNFa and NO, respectively. The specific QTL genes have not yet been identified but the fact that they regulate two well-known arthritis mediators underscores the potential importance of their identification.
In other sets of experiments it was determined that Cia5a regulates levels of autoantibodies against type II collagen 31 and numbers of CD4 þ CD45RC lo rat regulatory T cells (T reg ). 69 The Cia5a interval does not contain FoxP3 or other genes known to regulate T reg development. Therefore, it is anticipated that the gene accounting for Cia5a will be a novel regulator of T reg development or differentiation, and perhaps generate a novel way of treating disease.
A third example of functional studies in congenics was the observation that Cia10 controls cartilage and bone damage via yet unknown mechanisms. 30 For another locus that also regulates cartilage and bone destruction, Cia5d, 31 we have evidence implicating it in the regulation of the invasive properties of the fibroblast-like synoviocyte (Laragione et al., manuscript in preparation). To our knowledge this is the first evidence of a strong genetic component in the regulation of the FLS phenotypes.
Advanced intercross lines to refine arthritis QTL intervals
Advanced intercross line breeding is an additional strategy that has been used to refine arthritis QTL intervals. 70, 71 To generate these lines, heterozygous
Contribution of genetic studies in rodents to rheumatoid arthritis PS Gulko offspring from the parental inbred strains are intercrossed for several generations avoiding brother-sister mating. This approach requires large numbers of offspring and generates an increased number of recombination events. After phenotyping the offspring, dense genotyping across the region of interest allows for improved resolution. A similar strategy has also been used to refine congenic intervals or to study the interaction of two QTL congenic intervals.
72,73

Studying epistatic interactions
One characteristic of complex traits is that two loci may interact with each other, requiring genotype-based adjustments for their identification. 74 Depending on the population size, the genotype-associated relative risk and the type of analysis being used one may not have enough statistical power to detect interacting loci in human studies. Furthermore, genome-wide analyses looking for MHC interactions with non-MHC susceptibility loci identified modest 5, 6, 75 or no effect, 13 and no epistatic interactions between non-MHC loci were analyzed.
The importance of considering epistatic interactions in genetic analysis is further exemplified by studies with FCRL3. This gene was originally associated with RA in a Japanese study. 76 However, association studies could not replicate those findings in different Caucasian populations. 77, 78 More recently, a Canadian study that considered interactions of genes previously associated with RA identified a modestly significant association of FCRL3-169C polymorphism in PTPN22 1858T-homozygous Caucasian patients. 79 Large rodent offspring generated in experimental intercrosses facilitated the identification of epistatic loci outside the MHC (Cia7 with Cia26) 80 and between MHC and non-MHC CIA and AIA loci. [40] [41] [42] Furthermore, studies in advanced intercross lines, 72, 81 bi-congenic 82 and subcongenic strains 31 identified interacting loci in different chromosomes or within the same chromosome. Therefore, epistatic interactions and their functional characterization can be more easily and convincingly characterized in rodents and subsequently tested in RA in a gene-gene specific manner.
Gender-gene interactions
RA is more prevalent among females (3:1 male). Females also develop more erosive disease and require joint replacements more often than males. 83, 84 Gonadal hormones have been suggested to account for part of that difference. However, recent evidence suggests that yet unknown gender specific factors interact with specific disease genes to regulate disease susceptibility or severity. Data from humans and rodents suggest that some disease genes operate in a gender-specific, or gender-predominant manner. For example, a singlenucleotide polymorphism (SNP) in the IL-3 gene promoter has been associated with susceptibility to RA in female subjects compared with female controls (P ¼ 0.000004), but not in males. 85 Another example is the recent Wellcome Trust genome-wide study which detected a SNP on chromosome 7 (rs11761231) which was associated with RA only in females (P ¼ 6.8 Â 10
À8
). 24 Similar gender specific effects have been detected in rat and mouse intercrosses or congenic strains. 33, 57, 80 Sex chromosomes have also been implicated in the regulation of autoimmune arthritis. The Yaa locus in mice unexpectedly reduced CIA severity. 86 It remains unclear how the Yaa locus ameliorates disease, particularly in light of new evidence showing the Yaa involves a TLR7 translocation. 87 The Y chromosome in the DA Â ACI F2 rat intercross was also associated with milder CIA. 41 X chromosome susceptibility and severity loci have also been identified in RA 5, 9 and in rat CIA, 44 respectively. Once identified, the specific rodent arthritis genes' interactions with gender-related factors will be functionally characterized using hormonal manipulations, promoter studies and other strategies. That kind of information could ultimately be the starting point for gender-specific therapeutics.
Targeting susceptibility versus severity
It is anticipated that the human susceptibility genes identified in association studies will generate new targets for drug development. However, it is likely that some of the susceptibility genes will neither be feasible targets for therapy nor have a critical role in the regulation of established/chronic disease. Specifically, it is conceivable that at least some of the susceptibility genes will regulate early preclinical events during the immune response. Once the disease advances and additional pathogenic and proinflammatory pathways are recruited, early triggering events may become less relevant to the persistence of disease and to joint destructive processes. Therefore, emphasis on the genetic regulation of arthritis severity and joint damage may have increased potential of identifying genes controlling active and chronic disease.
Disease severity and joint damage has been actively studied in rodent models, 29, [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] and like in the Ncf1 case, other severity genes will be soon identified and will generate candidates for association studies in RA.
How are the genes identified in autoimmune arthritis models relevant to RA?
The role of arthritis genes identified in rodent models can be confirmed with several different strategies, which include gene complementation, such as the introduction of a knock-in wild-type allele, or transgenic overexpression in case the disease allele is associated with decreased function. Additionally, depending on the type of mutation/polymorphism (gain versus loss of function) different strategies can be used to correct gene function, and agonists/antagonists developed. The information generated from rodent studies will be highly informative to RA in at least three basic ways:
(1) Identification of candidate genes for focused association studies in humans. Many of the loci controlling experimental arthritis are syntenic to susceptibility loci detected in RA and other autoimmune diseases ( Table 1 ). While that does not prove that the rodent arthritis genes are the same as the RA genes, it certainly suggests that this is the case. Once the rat or mouse arthritis genes have been identified they can be tested in association studies for susceptibility to RA.
Most rodent studies focus on severity, while RA studies have been more focused on susceptibility. In other words, different phenotypes are being probed. Thus it is not surprising that not all rodent arthritis loci have a RA syntenic counterpart. To address that issue properly it will be important to study a RA cohort well characterized for disease severity parameters, including radiographic damage.
(2) Identification of pathways, cellular processes, and cell subsets, critical for the development of arthritis, which can then be studied (multiple genes per pathway) in genetic association studies in RA. Another possibility is that the specific rodent arthritis gene will not be replicated in RA susceptibility or severity, but will identify an important cellular and molecular pathway critical for disease pathogenesis. Other gene members of this pathway can then be studied in association studies for susceptibility and/or severity in RA.
(3) Identification of a gene or pathway critical for the development of arthritis that can be modulated in rodents (new target), thus generating novels therapies, even if that gene is not associated with RA in human studies. The most obvious rationale for studying the genetic regulation of rodent models of arthritis is listed in (1) and (2) above. However, it is important to remember that the relevance of rodent arthritis genes to RA is not conditional on confirming their association in human studies. Specifically, one can also view rodent arthritis genetic studies as a model system to identify key mediators in the pathogenesis of arthritis. While those genes might still be critical to the pathogenesis of RA, they can be modulated or induced at a somatic level and do not necessarily have to be genetically controlled in humans to be important. For example, highly effective therapies that target TNFa, [88] [89] [90] emerged from functional studies and did not require any genetic association study in RA. The same may apply to some of the new rodent arthritis genes that will continue to be discovered and studied in the next few years.
Conclusion
This is a very exciting time for the understanding of the pathogenesis and genetic regulation of RA. Technologic advances have greatly facilitated high-throughput genotyping and reduced costs for sequencing. The availability of human and rodent genome sequences and several public resources makes gene discoveries and studies much easier. A few genes have already been identified in RA and rodent models, and more genes will be identified within the next few years. Animal models will continue to have a major role in facilitating the identification of important arthritis genes, and also in understanding how arthritis genes operate to regulate disease. Rodent studies will continue to generate novel and better targets for therapeutic intervention, as well as potentially novel prognostic and diagnostic biomarkers to be tested in RA.
